Investor Overview

Corporate Profile

Investor Highlights

Corporate Profile

Read Now

Corporate Profile

Investor Presentation

Read Now


Our Pipeline

Learn More
  • Price
  • Change

  • Copyright West LLC.
    Minimum 15 minutes delayed.
Recent Releases

Recent Releases

November 23, 2020

BeiGene to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference

November 19, 2020

BeiGene Announces the Approval of XGEVA® (Denosumab) in China for the Prevention of Skeletal-Related Events in Patients With Bone Metastases From Solid Tumors and in Patients With Multiple Myeloma

November 17, 2020

BeiGene Announces that RATIONALE 303 Trial of Tislelizumab in Non-Small Cell Lung Cancer Met the Primary Endpoint of Overall Survival at Interim Analysis

Key Metrics

Key Metrics

  • 4,700+


  • 1,300+

    Clinical team

  • 5


This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.